[go: up one dir, main page]

MX2011009256A - Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas. - Google Patents

Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas.

Info

Publication number
MX2011009256A
MX2011009256A MX2011009256A MX2011009256A MX2011009256A MX 2011009256 A MX2011009256 A MX 2011009256A MX 2011009256 A MX2011009256 A MX 2011009256A MX 2011009256 A MX2011009256 A MX 2011009256A MX 2011009256 A MX2011009256 A MX 2011009256A
Authority
MX
Mexico
Prior art keywords
anionic oil
oil
water emulsions
emulsions containing
water
Prior art date
Application number
MX2011009256A
Other languages
English (en)
Inventor
Betty Philips
Frederic Lallemand
Jean-Sebastien Garrigue
Original Assignee
Novagali Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagali Pharma Sa filed Critical Novagali Pharma Sa
Publication of MX2011009256A publication Critical patent/MX2011009256A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a una emulsión aniónica aceite- en-agua coloidal que comprende una prostaglandina, un aceite teniendo un valor de yodo = 2, un surfactante y agua, siempre que la emulsión aniónica aceite-en-agua no contenga alcohol polivinílico. La presente invención también pertenece al uso de dichas emulsiones aniónicas aceite-en-agua para intensificar la estabilidad de dichas prostaglandinas, para el tratamiento e hipertensión ocular y/o glaucoma, para promover el crecimiento de pestañas y/o para tratar hipotricosis de pestañas.
MX2011009256A 2009-03-04 2010-03-04 Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas. MX2011009256A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15734709P 2009-03-04 2009-03-04
EP09305203A EP2228058A1 (en) 2009-03-04 2009-03-04 Anionic oil-in-water emulsion containing prostaglandins and uses thereof
PCT/EP2010/052740 WO2010100217A1 (en) 2009-03-04 2010-03-04 Anionic oil-in-water emulsions containing prostaglandins and uses thereof

Publications (1)

Publication Number Publication Date
MX2011009256A true MX2011009256A (es) 2011-09-27

Family

ID=40626733

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009256A MX2011009256A (es) 2009-03-04 2010-03-04 Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas.

Country Status (12)

Country Link
US (1) US9089480B2 (es)
EP (2) EP2228058A1 (es)
JP (1) JP5722802B2 (es)
KR (2) KR101879381B1 (es)
CN (1) CN102341093B (es)
AU (1) AU2010220321B2 (es)
CA (1) CA2754156C (es)
ES (1) ES2572373T3 (es)
HK (1) HK1166608A1 (es)
IL (1) IL214506A (es)
MX (1) MX2011009256A (es)
WO (1) WO2010100217A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1655021B1 (en) * 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
CA2681668C (en) 2006-03-23 2014-04-01 Michael S. Singer Compositions comprising prostaglandin f2-alpha analogs and methods for reducing body fat
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
ES2616089T3 (es) 2010-09-21 2017-06-09 S & V Technologies Gmbh Composición cosmética
CA2866067C (en) 2011-01-19 2015-04-21 Topokine Therapeutics, Inc. Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
US20140322428A1 (en) 2013-03-15 2014-10-30 Leading Edge Innovations, LLC Compositions having an oil-in-water dispersion of submicron particles to enhance foods and beverages
NO2753788T3 (es) * 2013-05-10 2018-06-16
US9820993B2 (en) 2013-05-15 2017-11-21 Topokine Therapeutics, Inc. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
WO2015200425A1 (en) 2014-06-27 2015-12-30 Topokine Therapeutics, Inc. Topical dosage regimen
PL427837A1 (pl) * 2018-11-22 2020-06-01 Gbj Pharma Spółka Z Ograniczoną Odpowiedzialnością Systemy do ciągłego obwodowego podawania latanoprostu dla obniżania ciśnienia śródgałkowego
CN111840225B (zh) * 2020-08-12 2021-09-14 陈丽娜 一种用于治疗青光眼的滴眼剂及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
JPH0818989B2 (ja) 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JP2602964B2 (ja) 1989-10-16 1997-04-23 裕 水島 プロスタグランジン類縁体およびその脂肪乳剤
IL101241A (en) 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
DE69411816T2 (de) 1993-06-25 1998-12-03 Alcon Cusi, S.A., El Masnou, Barcelona Neue Verwendung von polymeren Membranen zum Ausgeben von pharmazeutischen Lösungen, die quarternäre, als Konserviermittel dienende Ammoniumverbindungen enthalten und entsprechender Dosierbehälter
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6066671A (en) 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
FR2823441B1 (fr) 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
US20040198829A1 (en) 2001-04-23 2004-10-07 Sponsel William Eric Prostanoids augment ocular drug penetration
ATE468107T1 (de) 2001-11-01 2010-06-15 Yissum Res Dev Co Verfahren und zusammensetzung zur behandlung von trockenen augen
KR100446960B1 (ko) 2001-12-04 2004-09-01 김종국 프로스타글란딘 ｅ1을 포함하는 온도감응성 에멀젼 외용제조성물
US20050124699A1 (en) 2002-07-02 2005-06-09 Wakamoto Pharmaceutical Co., Ltd. Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
WO2004024164A1 (ja) 2002-08-23 2004-03-25 Santen Pharmaceutical Co., Ltd. ラタノプロストを有効成分とする安定な点眼液
AU2003261981A1 (en) 2002-09-09 2004-03-29 Santen Pharmaceutical Co., Ltd. Transparent eye drops containing latanoprost
US20040115234A1 (en) 2002-09-24 2004-06-17 Gewirtz Joan T. Cosmetic composition
US7074827B2 (en) 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
WO2005044276A1 (ja) 2003-11-07 2005-05-19 Senju Pharmaceutical Co., Ltd. プロスタグランジン含有医薬組成物
EP1655021B1 (en) 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
DK1809238T3 (da) 2004-11-09 2010-01-25 Novagali Pharma Sa Ophthalmiske emulsioner indeholdende et immunosuppressivt middel
PT1937212E (pt) 2005-10-10 2010-11-30 Novagali Pharma Sa Emulsões oftálmicas contendo prostaglandinas
TWI376239B (en) 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
CN101400354B (zh) 2006-03-13 2014-10-22 株式会社·R-技术上野 水性组合物
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
TWI394564B (zh) 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
ZA200901164B (en) 2006-09-21 2010-06-30 Alcon Res Ltd Self preserved aqueous pharmaceutical compositions
US9364461B2 (en) 2006-12-21 2016-06-14 Santen Sas Process for manufacturing ophthalmic oil-in-water emulsions
US20080234376A1 (en) * 2007-03-21 2008-09-25 Taiwan Liposome Company (A Taiwan Corporation) Emulsion composition comprising prostaglandin e1
EP1985298A1 (en) * 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
US20090298956A1 (en) 2008-05-28 2009-12-03 Chowhan Masood A Self-preserved emulsions
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
EP2228057A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Cationic oil-in-water emulsions containing prostaglandins and uses thereof
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions

Also Published As

Publication number Publication date
KR101879381B1 (ko) 2018-08-16
IL214506A (en) 2016-08-31
US9089480B2 (en) 2015-07-28
KR101786760B1 (ko) 2017-10-18
CA2754156A1 (en) 2010-09-10
US20110319488A1 (en) 2011-12-29
KR20120003856A (ko) 2012-01-11
HK1166608A1 (en) 2012-11-02
KR20170052695A (ko) 2017-05-12
AU2010220321B2 (en) 2015-08-20
ES2572373T3 (es) 2016-05-31
JP2012519664A (ja) 2012-08-30
CN102341093B (zh) 2014-08-27
EP2228058A1 (en) 2010-09-15
CA2754156C (en) 2017-06-06
CN102341093A (zh) 2012-02-01
JP5722802B2 (ja) 2015-05-27
EP2403478A1 (en) 2012-01-11
IL214506A0 (en) 2011-09-27
WO2010100217A1 (en) 2010-09-10
AU2010220321A1 (en) 2011-09-01
EP2403478B1 (en) 2016-03-02

Similar Documents

Publication Publication Date Title
MX2011009256A (es) Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas.
WO2010111267A3 (en) Personal-care composition comprising a cationic active
WO2014081950A3 (en) Fabric care compositions comprising emulsions
WO2012006526A3 (en) Skin care w/o emulsion composition
EP4302734A3 (en) Ocular delivery systems and methods
WO2013178683A3 (de) N-methyl-n-acylglucamin enthaltende zusammensetzung
FR2938437B1 (fr) Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
WO2013130948A3 (en) Sunscreen composition comprising uv composite
WO2008083092A3 (en) Polynuclear microcapsules
WO2013064391A3 (en) Cosmetic or dermatological preparation for application on wet skin
WO2012016000A3 (en) Preservative free brimonidine and timolol solutions
ECSP11011395A (es) Emulsiones nutritivas con un contenido elevado de fibras
WO2012015998A3 (en) Preservative free bimatoprost and timolol solutions
MX2011009258A (es) Emulsiones aceite-en-agua cationicas conteniendo prostaglandinas y usos de las mismas.
PH12022550262A1 (en) Oil-in-water emulsion comprising plant protein
RU2011152889A (ru) Косметическая композиция для ухода за кожей на основе эмульсии "масло в воде"
WO2014097258A3 (en) Aqueous cosmetic composition comprising alkylcellulose
ZA202108950B (en) Oxymetazoline compositions and methods for treating ocular disorders
PH12016501902A1 (en) Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed
IN2014CN04809A (es)
BR112012017319A2 (pt) composições e métodos para abaixar a pressão intraocular
RU2013146037A (ru) Косметическая композиция в виде эмульсии вода-в-масле
WO2012015996A3 (en) Preservative free bimatoprost solutions
EA201991379A1 (ru) Новые наноэмульсии, содержащие глицерин в водной фазе
RU2013146038A (ru) Косметическая композиция в виде эмульсии вода-в-масле

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: BASF SE